Insider Trading Alert - Microsemi And 4 Others Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Sept. 13, 2013, 141 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $99.99 to $478,779,119.37.

Highlighted Stocks Traded by Insiders:

Microsemi (MSCC) - FREE Research Report

Anderson Thomas Robert who is Director at Microsemi sold 1,000 shares at $25.97 on Sept. 13, 2013. Following this transaction, the Director owned 14,616 shares meaning that the stake was reduced by 6.4% with the 1,000 share transaction.

The shares most recently traded at $26.08, up $0.11, or 0.42% since the insider transaction. Historical insider transactions for Microsemi go as follows:

  • 4-Week # shares sold: 1,000
  • 12-Week # shares sold: 1,000
  • 24-Week # shares sold: 36,000

The average volume for Microsemi has been 456,100 shares per day over the past 30 days. Microsemi has a market cap of $2.4 billion and is part of the technology sector and electronics industry. Shares are up 22.29% year to date as of the close of trading on Friday.

http://www.microsemi.com/applications/medical http://www.microsemi.com/applications/medical/medical-wearable-wireless http://www.microsemi.com/company/acquisitions Company has done a lot of acquisitions Based on corporate presentation posted on website, looks like Medtronic, St. The company has a P/E ratio of 55.9. Currently there are 6 analysts that rate Microsemi a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MSCC - FREE

TheStreet Quant Ratings rates Microsemi as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, expanding profit margins, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Microsemi Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

UGI Corporation (UGI) - FREE Research Report

Greenberg Lon R who is Director at UGI Corporation sold 25,372 shares at $38.77 on Sept. 13, 2013. Following this transaction, the Director owned 382,063 shares meaning that the stake was reduced by 6.23% with the 25,372 share transaction.

The shares most recently traded at $38.22, down $0.55, or 1.44% since the insider transaction. Historical insider transactions for UGI Corporation go as follows:

  • 4-Week # shares bought: 6,800
  • 4-Week # shares sold: 18,343
  • 12-Week # shares bought: 6,800
  • 12-Week # shares sold: 18,343
  • 24-Week # shares bought: 6,800
  • 24-Week # shares sold: 18,343

The average volume for UGI Corporation has been 533,000 shares per day over the past 30 days. UGI Corporation has a market cap of $4.4 billion and is part of the utilities sector and utilities industry. Shares are up 16.91% year to date as of the close of trading on Friday.

Natural Gas Utility, (NYSE: UGI), distributor and marketer of energy products and services. The stock currently has a dividend yield of 2.94%. The company has a P/E ratio of 16.2. Currently there is 1 analyst that rates UGI Corporation a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UGI - FREE

TheStreet Quant Ratings rates UGI Corporation as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, revenue growth, reasonable valuation levels and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full UGI Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

CACI International (CACI) - FREE Research Report

Phillips Warren R who is Director at CACI International sold 975 shares at $66.80 on Sept. 13, 2013. Following this transaction, the Director owned 6,556 shares meaning that the stake was reduced by 12.95% with the 975 share transaction.

The shares most recently traded at $67.87, up $1.07, or 1.58% since the insider transaction. Historical insider transactions for CACI International go as follows:

  • 24-Week # shares sold: 16,212

The average volume for CACI International has been 249,100 shares per day over the past 30 days. CACI International has a market cap of $1.6 billion and is part of the services sector and diversified services industry. Shares are up 22.33% year to date as of the close of trading on Friday.

CACI International Inc, through its subsidiaries, provides information solutions and services to the U.S. federal government and commercial markets in North America and internationally. The company has a P/E ratio of 10.6. Currently there is 1 analyst that rates CACI International a buy, 3 analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CACI - FREE

TheStreet Quant Ratings rates CACI International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, attractive valuation levels and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full CACI International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Biogen Idec (BIIB) - FREE Research Report

Schenk Lynn who is Director at Biogen Idec sold 900 shares at $235.25 on Sept. 13, 2013. Following this transaction, the Director owned 3,325 shares meaning that the stake was reduced by 21.3% with the 900 share transaction.

The shares most recently traded at $238.18, up $2.93, or 1.23% since the insider transaction. Historical insider transactions for Biogen Idec go as follows:

  • 4-Week # shares sold: 6,607
  • 12-Week # shares sold: 11,085
  • 24-Week # shares sold: 51,721

The average volume for Biogen Idec has been 1.3 million shares per day over the past 30 days. Biogen Idec has a market cap of $55.6 billion and is part of the health care sector and drugs industry. Shares are up 59.94% year to date as of the close of trading on Friday.

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. The company has a P/E ratio of 34.7. Currently there are 12 analysts that rate Biogen Idec a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BIIB - FREE

TheStreet Quant Ratings rates Biogen Idec as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Biogen Idec Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

American Equity Investment Life Holding Com (AEL) - FREE Research Report

Richardson Debra J who is Executive VP & Secretary at American Equity Investment Life Holding Com sold 1,000 shares at $20.85 on Sept. 13, 2013. Following this transaction, the Executive VP & Secretary owned 119,924 shares meaning that the stake was reduced by 0.83% with the 1,000 share transaction.

The shares most recently traded at $21.00, up $0.15, or 0.7% since the insider transaction.

The average volume for American Equity Investment Life Holding Com has been 1.1 million shares per day over the past 30 days. American Equity Investment Life Holding Com has a market cap of $1.4 billion and is part of the financial sector and insurance industry. Shares are up 71.33% year to date as of the close of trading on Friday.

American Equity Investment Life Holding Company, through its subsidiaries, operates in the insurance business in 50 states and the District of Columbia. The stock currently has a dividend yield of 0.72%. The company has a P/E ratio of 8.3. Currently there are 5 analysts that rate American Equity Investment Life Holding Com a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on AEL - FREE

TheStreet Quant Ratings rates American Equity Investment Life Holding Com as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, compelling growth in net income, attractive valuation levels and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full American Equity Investment Life Holding Com Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet

Ford, GM Gain as China Slashes Auto Import Tariffs

Ford, GM Gain as China Slashes Auto Import Tariffs

U.S. Crude Oil Hits Fresh 3-Year Highs as Gasoline Heads to $3 a Gallon

U.S. Crude Oil Hits Fresh 3-Year Highs as Gasoline Heads to $3 a Gallon